The study revealed that aspirin may operate through various biological pathways, making it effective in reducing cancer risk. One of the primary mechanisms at play is aspirin’s ability to reduce ...

(2) a positive correlation with the potency of NSAIDs to inhibit COX and their potency to induce asthmatic attacks; and (3) cross-desensitization to other NSAIDs after desensitization to aspirin.

This syndrome is referred to as aspirin-induced asthma (AIA). The pathogenesis of AIA has implicated both the lipoxygenase (LO) and the cyclooxygenase (COX) pathways. By inhibiting the COX pathway ...

Aspirin reduced colorectal cancer recurrence risk by 50% in patients with PIK3CA mutations over three years. Mutations in the PI3K pathway predict aspirin response, broadening its use to more patients ...

"Aspirin 160 mg reduced recurrence by more than 50% in colorectal cancer patients with tumors harboring mutations in the PI3 kinase pathway," said Martling. "This is the first trial to show that ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations ...